跳至主要内容
临床试验/CTRI/2025/12/099418
CTRI/2025/12/099418尚未招募2 期

Clinical Efficacy Of Unani Formulations Araq Mundi (Sphaeranthus Indicus) And Raughan Kamela (Mallotus Philipensis) In NarFarsi (Eczema): A Randomized Open Labelled Comparative Clinical Trial

Govt Unani Medical College1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2026年1月2日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
78
试验地点
1
主要终点
Reduction in EASI Score from baseline

研究概览

简要总结

NarFarsi(Eczema) is an inflammatory condition of skin .The disease manifests as Pruritus, erythema ,edema ,vesicles, scaling and lichenification[1]Eczema is classified into two broad groups .1)Exogenous: where external stimuli trigger development of eczema e.g Irritant dermatitis. 2) Endogenous:where constitutional factors predispose the patient to developing an eczema e.g Atopic dermatitis .According to Unani system of medicine it may be caused by su i mizaj sada and su i mizaj maddi due to abnormal Akhlat involvement , the cause include safra(yelow bile) mixed with sawda(black bile)or Hadd safra (acrid yellow bile )mixed with Dam (sanguine). The treatment modulation of NarFarsi includes ingredients with anti inflammatory ,blood purifying (musaffi e dam) immunomodulatory and skin soothing effects. This integrative approach addresses symptoms and immune balance while aiming to restore skin barrier function.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Age 18 years to 60years 2.Both gender 3.Diagnosis made on the basis of Hannifin and Rajka criteria 4.Eczema of mild to moderate in severity 5.Participants who have agreed to sign the informed consent form.

排除标准

  • 1.Participants below 18 and above 60 years of age 2.Participants with Autoimmune and other skin diseases 3.Eczema due to secondary infection 4.Pregnant and lactating women 5.Participant not willing to attend treatment schedule regularly.

结局指标

主要结局

Reduction in EASI Score from baseline

时间窗: Baseline | 2nd week | 4th week | 6th week

次要结局

  • Improvement in DLQI Score from baseline(Improvement in SCORAD from baseline)

研究者

发起方
Govt Unani Medical College
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Farzana Anjum A

Government Unani Medical College Chennai

研究点 (1)

Loading locations...

相似试验